Kerala Reports 300 New Active COVID-19 Cases, 3 Deaths
Responding to the escalating crisis, the Union Health Ministry has intensified surveillance efforts and announced reinforced precautionary measures, extending the vigilance to multiple states effective immediately. In a high-level meeting on Wednesday, Union Minister Mansukh Mandaviya urged states to conduct more inspections, emphasizing the importance of joint efforts between the central government and states to manage the virus efficiently.
Mandaviya underscored the need for heightened preparedness against emerging strains of COVID-19, calling for regular mock drills at both central and state levels to share best practices. States have been instructed to closely monitor emerging evidence of COVID-19 cases, symptoms, and case severity to plan appropriate public health responses.
The Union Health Ministry has also advised all states and Union Territories (UTs) to send samples of all Covid-positive cases to Indian SARS-CoV-2 Genomics Consortium (INSACOG) labs to facilitate tracking of new variants.
Regarding the newly identified JN.1 subvariant, the health ministry assured the public that though it is under intense scientific scrutiny, it does not pose an immediate concern. The World Health Organization (WHO) classified JN.1 as a "variant of interest," emphasizing that current evidence indicates a low risk to public health. Symptoms of the JN.1 subvariant include mild fever, coughing, nasal discomfort, sore throat, runny nose, facial pain or pressure, headache, and gastrointestinal issues.
Sudhansh Pant, secretary of the Union Health Ministry, highlighted that while active COVID cases in India remain significantly lower than the global scenario, there has been a sharp rise in the past two weeks, reaching 614 on December 20 from 115 on December 6. Notably, 92.8% of cases are home-isolated, indicating a mild illness. The ministry emphasized that the increase in the daily positivity rate has been observed in states such as Kerala, Maharashtra, Jharkhand, and Karnataka.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment